Company profile
Remegen company profile
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.
Business identity
- Website
- https://www.remegen.com/
- Contact email
- [email protected]
- Phone number
- +86 05353573511
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1,001-5,000 employees
- Revenue range
- $10M-$100M
- Founded
- 2008-01-01, Year
Headquarters
- Headquarters
- Yijing, Shanxi, China
- Country code
- CN
- Continent
- Asia